Matthew C Kapusta Uni Qure N.V. (QURE) insider trading activity

Matthew C Kapusta is CEO, Managing Director of uniQure N.V.. Currently has a direct ownership of 590,839 shares of QURE, which is worth approximately $3.2 Million. The most recent transaction as insider was on Jan 27, 2021, when has been sold 15,749 shares (Ordinary Shares) at a price of $37.45 per share, resulting in proceeds of $589,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 591K

0% 3M change

26.05% 12M change

Total Value Held $3.2 Million

Matthew C Kapusta Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 27 2021	SELL Open market or private sale	$589,800 $37.45 p/Share	15,749 Reduced 5.94%	249,488 Ordinary Shares
Jan 27 2021	SELL Open market or private sale	$589,800 $37.45 p/Share	15,749 Reduced 5.94%	249,488 Ordinary Shares
Dec 16 2020	SELL Open market or private sale	$607,424 $48.59 p/Share	12,501 Reduced 4.5%	265,237 Ordinary Shares
Dec 16 2020	BUY Exercise of conversion of derivative security	$94,133 $7.53 p/Share	12,501 Added 4.31%	277,738 Ordinary Shares
Nov 19 2020	SELL Open market or private sale	$513,019 $45.18 p/Share	11,355 Reduced 4.11%	265,237 Ordinary Shares
Nov 19 2020	BUY Exercise of conversion of derivative security	$23,531 $7.53 p/Share	3,125 Added 1.12%	276,592 Ordinary Shares
Nov 18 2020	SELL Open market or private sale	$453,050 $43.93 p/Share	10,313 Reduced 3.63%	273,467 Ordinary Shares
Nov 18 2020	BUY Exercise of conversion of derivative security	$24,216 $7.53 p/Share	3,216 Added 1.12%	283,780 Ordinary Shares
Oct 14 2020	SELL Open market or private sale	$189,840 $36.16 p/Share	5,250 Reduced 1.84%	280,564 Ordinary Shares

Also insider at

DBTX

Decibel Therapeutics, Inc. Healthcare

Director

MCK